They were randomized to one of three treatment arms : metformin ( MET ) arm 1000 mg BID , liraglutide ( LIRA ) arm 1.2 mg QD s.c. , or combined MET 1000 mg BID and LIRA ( COMBI ) 1.2 mg QD s.c. Lifestyle intervention was not actively promoted .